License and Collaboration Revenue - Narrative (Details) $ in Thousands, € in Millions		1 Months Ended			12 Months Ended
	Nov. 26, 2022 USD ($) product	May 31, 2023 USD ($)	Jul. 31, 2021 USD ($)	Jul. 31, 2021 EUR (€) item	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Nov. 16, 2022 item
License and Collaboration Revenue
Contract liability					$ 400	$ 0
Net Contract Liability					17,545	16,285
Collaboration revenue
License and Collaboration Revenue
Collaboration revenue					54	15,671
Cost of revenue					25	150
Collaboration Agreement with Orion
License and Collaboration Revenue
Upfront fee received			$ 29,600	€ 25.0
Number of days from receipt of the final report, in which the collaboration agreement may be terminated			90 days	90 days
Percentage of upfront fee which must be refunded in the event of termination				75.00%
Amount of payment receivable upon achievement of specific clinical and commercial achievements | €				€ 97.0
Term of collaboration agreement			10 years	10 years
Number of performance obligations | item				3
Number of commitments represent distinct performance | item				3
Collaboration revenue						12,700
Transaction Price					37,880	37,880
Contract liability					13,709	15,062
Net Contract Liability					10,797	10,000
Offset by contract asset					2,912	5,079
Incremental costs incurred in obtaining the agreement					2,000
Capitalized contract costs					900
Collaboration Agreement with Orion | Selling, general and administrative
License and Collaboration Revenue
Contract acquisition costs included in selling, general and administrative expense					1,100
Collaboration Agreement with Orion | License Revenue
License and Collaboration Revenue
Collaboration revenue						12,700
Transaction Price					21,660	21,660
Collaboration Agreement with Orion | Development and Regulatory Services
License and Collaboration Revenue
Amortization of transaction price as a reduction of research and development costs					1,400	1,100
Transaction Price					6,717	6,717
Contract liability					4,206	5,559
Collaboration Agreement with Orion | Supply of License Product
License and Collaboration Revenue
Transaction Price					9,503	9,503
Contract liability					9,503	9,503
Collaboration Agreement with Tenacia
License and Collaboration Revenue
Upfront fee received						$ 10,000
Aggregate amount	$ 256,000
Milestone regulatory approvals	15,000
Aggregative sales based milestone	$ 241,000
Term of collaboration agreement						45 days
Number of performance obligations | item							2
Number of commitments represent distinct performance | item							2
Transaction Price					10,000
Contract liability					7,002	$ 7,000
Net Contract Liability					6,302
Offset by contract asset					700	700
Incremental costs incurred in obtaining the agreement						1,000
Capitalized contract costs						700
Cost of revenue						200
Number of Selected Products to which milestone payments applicable | product	1
Collaboration Agreement with Tenacia | Selling, general and administrative
License and Collaboration Revenue
Contract acquisition costs included in selling, general and administrative expense						$ 100
Collaboration Agreement with Tenacia | License Revenue
License and Collaboration Revenue
Collaboration revenue					0
Transaction Price					2,998
Collaboration Agreement with Tenacia | Supply of License Product
License and Collaboration Revenue
Transaction Price					7,002
Contract liability					7,002
Biologix Distribution and Supply Agreement
License and Collaboration Revenue
Upfront fee received		$ 500
Biologix Distribution and Supply Agreement | Maximum
License and Collaboration Revenue
Collaboration revenue					100
Cost of revenue					$ 100